Congratulations on Rivastigmine Tartrate Project Passed the On-site Verification by a Listed Pharmaceutical Company
Release Time:
2018-07-25 20:57
Source:
Biortus has passed the on-site verification of active pharmaceutical ingredient (API) Rivastigmine tartrate process development by a listed pharmaceutical company. Our process research and development team has gained invaluable experience from the successful completion of the Rivastigmine tartrate project. Having become more competent and experienced in API development along with continuous improvement, we are ready to take on new projects.
Next Page
CONTACT US
Telephone：(781)201-9739
Adresse：Block A5, 6 Dongsheng West Road Jiangyin, Jiangsu Province 214437 People’s Republic of China
E-mail：info@wuxibiortus.com
FOLLOW US
Copyright © 2020 Wuxi Biortus Biosciences Co. Ltd. 苏ICP备15024653号-1 Power by www.300.cn